Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium

Fig. 2

Treatment and survival outcomes. The patients were divided into four groups: cytarabine-based chemotherapy with or without HSCT, and non-cytarabine-based chemotherapy with or without HSCT. The OS and PFS of the entire cohort (A and B), the older cohort (C and D), and the younger cohort (E and F) are shown

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us